HomeMDG1 ā¢ FRA
add
MediGene AG
Previous close
ā¬0.030
Day range
ā¬0.030 - ā¬0.030
Year range
ā¬0.019 - ā¬1.55
Market cap
417.17K EUR
Avg Volume
3.81K
P/E ratio
-
Dividend yield
-
Primary exchange
FRA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.46M | -6.00% |
Operating expense | 5.22M | ā |
Net income | -4.08M | ā |
Net profit margin | -280.10 | ā |
Earnings per share | ā | ā |
EBITDA | -3.75M | ā |
Effective tax rate | ā | ā |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.02M | ā |
Total assets | 28.81M | ā |
Total liabilities | 9.15M | ā |
Total equity | 19.66M | ā |
Shares outstanding | 14.74M | ā |
Price to book | 0.02 | ā |
Return on assets | ā | ā |
Return on capital | -44.32% | ā |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -4.08M | ā |
Cash from operations | -3.54M | ā |
Cash from investing | 3.85M | ā |
Cash from financing | 2.36M | ā |
Net change in cash | 2.68M | ā |
Free cash flow | ā | ā |
About
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia
Founded
1994
Headquarters
Website
Employees
87
